LUNG

Pulmonx Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth 3/10
  • Momentum 2/10
Pulmonx sales and earnings growth
LUNG Growth
Neutral
  • Revenue Y/Y 15.59%
  • EPS Y/Y 4.08%
  • FCF Y/Y 6.38%
Pulmonx gross and profit margin trends
LUNG Profitability
Neutral
  • Gross margin 73.30%
  • EPS margin -61.90%
  • ROIC -50.10%
Pulmonx net debt vs free cash flow
LUNG Risk
Great
  • Debt / Equity 0.9
  • Debt / FCF 0.0
  • Interest coverage -16.4

Pulmonx stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗